Source: Mishcon de Reya

Mishcon de Reya discusses the increasing use of artificial intelligence in the recruitment of patients for clinical trials. AI technologies improve the efficiency and accuracy of identifying suitable candidates by analyzing large datasets, medical records, and patient histories. This leads to faster recruitment, reduced costs, and enhanced trial outcomes.

The article also addresses ethical considerations, emphasizing the need to maintain patient privacy and consent while leveraging AI tools. It highlights how AI can overcome traditional recruitment bottlenecks, benefiting pharmaceutical companies, researchers, and patients alike. The use of AI in this field is positioned as a transformative step in clinical research.